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Abstract
Background: Few studies have evaluated access to and retention in pre-ART care.
Objectives: To evaluate the proportion of People Living With HIV (PLWH) in pre-ART and ART care and factors associated
with retention in pre-ART and ART care from a community cohort.
Methods: A cross sectional survey was conducted from February – April 2011. Self reported HIV positive, negative or
participants of unknown status completed a questionnaire on their HIV testing history, access to pre-ART and retention in
pre-ART and ART care.
Results: 872 randomly selected adults who reported being HIV positive in the ZAMSTAR 2010 prevalence survey were
included and revisited. 579 (66%) reconfirmed their positive status and were included in this analysis. 380 (66%) had
initiated ART with 357 of these (94%) retained in ART care. 199 (34%) had never initiated ART of whom 186 (93%) accessed
pre-ART care, and 86 (43%) were retained in pre-ART care. In a univariable analysis none of the factors analysed were
significantly associated with retention in care in the pre-ART group. Due to the high retention in ART care, factors associated
with retention in ART care, were not analysed further.
Conclusion: Retention in ART care was high; however it was low in pre-ART care. The opportunity exists, if care is better
integrated, to engage with clients in primary health care facilities to bring them back to, and retain them in, pre-ART care.
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Introduction
South Africa had an estimated HIV incidence of 0.94% in
adults in 2012 [1] with an estimated 6.1 million people living with
HIV (PLWH) of which 2.2 million were on antiretroviral therapy
(ART) [2]. There has been a strong drive to increase the numbers
of people testing for HIV and HIV counselling and testing (HCT)
occurs at all levels of the health care system, and within different
health care programmes such as the Prevention of Mother to
Child Transmission (PMTCT) programme and the Tuberculosis
(TB) programme. It is also offered at community sites, through
outreach drives and at the work place. This presents challenges to
ensure that clients who undergo HCT, irrespective of where it is
conducted, are linked to the appropriate follow up package of care,
support and treatment [1]. More focus is given within programmes
to PLWH who are on ART to ensure adherence to therapy than
to retention in pre-ART care for those not yet qualifying for ART.
Studies in South Africa show that the majority of persons who
initiate ART have low CD4 cell counts [3,4]. A report from the
IeDEA and ART cohort collaborations show that in South Africa
in 2007 women initiated ART at a median CD4 count of
124 cells/mm3 and men at 111 cells/mm3 [5]. Recent changes in
guidelines increasing CD4 eligibility to initiate ART may help to
improve this. Poor access to, or poor retention in pre-ART care,
may contribute to the low baseline CD4 at ART initiation, which
is associated with high mortality [6].
The standard of HIV care (2013) in South Africa includes
HCT, care prior to initiation on ART (pre-ART care) and
initiation and maintenance on ART (ART care). The target is for
80% of men and women aged 15–49 years (30 million) to have
been tested for HIV by 2016 [1]. CD4 cell count monitoring
should occur at six monthly intervals in PLWH not yet eligible for
ART and they should be retained in pre-ART care [1,6,7].
The majority of national ART programmes in sub Saharan
Africa report the number of people initiated and retained on ART
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with few reporting on pre-ART retention [8]. Pre-ART studies
looking at the proportion of PLWH who have had a CD4 count
after HIV diagnosis have reported a range from 55–78% [9–11].
Studies reporting on PLWH who returned for a follow up CD4
count have ranged from 26–45% [12,13].
A systematic review looking at retention in HIV care between
testing and treatment in sub-Saharan Africa estimated that only a
sixth to a third of patients who test positive for HIV are staged,
and enroll and remain in pre-ART care until they are eligible for
and have initiated ART [8]. There is little data on retention in
pre-ART care and more research is required.
We evaluated the proportion of PLWH in pre-ART and ART
care and factors associated with retention in pre-ART care from a
community cohort.
Methods
Setting, population and study design
This study was conducted in the Western Cape Province of
South Africa in eight communities with a high burden of HIV and
TB in the greater Cape Town area. All communities are served by
at least one public sector primary health care facility, which offers
HCT, pre-ART and ART care. This survey was conducted in
2011 when the South African guidelines stipulated that PLWH
with a CD4 count lower than 200 cells/mm3; or 350 cells/mm3 in
patients with TB or who were pregnant; or in patients with WHO
stage 4 disease irrespective of CD4 count, should commence ART
[7]. The change to initiate ART at CD4 ,350 cells/mm3 and for
all with tuberculosis or pregnant or breastfeeding [14], was
introduced after this survey was completed.
The sampling frame for this study comprised adults who were
previously part of a TB and HIV prevalence survey in 2010 as part
of the Zambia South Africa TB and AIDS Reduction (ZAM-
STAR) study [15] and whose self reported HIV status was known
from that survey. Randomly selected adults ($18 years old) from
each of the eight communities of the 2010 ZAMSTAR prevalence
survey [16] who had disclosed that they were HIV positive and
agreed to be contacted again, were revisited between February
and April 2011. After written informed consent was obtained, they
were asked to complete a questionnaire that focused on their HIV
testing history, access to pre-ART and retention in pre-ART and
ART care, as well as the last time they had attended a public
sector health care facility. In order to decrease stigmatisation that
may have resulted from visiting only the homes of self disclosed
HIV positive adults, in each community a small number of
randomly selected self disclosed HIV negative adults or adults who
did not know their HIV status were also revisited and asked to
complete the same questionnaire. However, only those who self
reported that they were HIV positive at the revisit were included
in this analysis.
Data collection and management
Lists of names of the randomly selected adults were generated
and unique barcodes printed for each selected adult. Trained
research assistants received the barcodes and management forms
and a separate list with the names and addresses of the selected
adults. The research assistants were unaware of the participant’s
HIV status and visited each participant in his/her home where
they barcoded the forms, obtained written informed consent,
interviewed the participant in their home language and completed
the questionnaire. The questionnaire data were recorded using the
scanned barcodes (no personal identifiers) on an electronic
personal data assistant (PDA) and downloaded on a daily basis
onto a server at the Desmond Tutu TB Centre (DTTC). Only the
data manager could link the unique barcode to the participant’s
name from the informed consent form. Data from the ques-
tionnaires were merged by the data manager to data (age, sex,
race, years lived in the area, and history of previous TB treatment)
from the ZAMSTAR 2010 prevalence survey.
Definitions
ART group: PLWH who self reported that they had been
initiated onto ART.
Retention in ART care: People in the ART group who self
reported that they had collected ART medication within the last
three months of being interviewed.
pre-ART group: PLWH who self reported that they had never
initiated ART.
Accessed pre-ART care: PLWH who self reported that they had
had at least one CD4 count.
Retention in pre-ART care: People in the pre-ART group who
self reported that they had had a CD4 count within 6 months of
being interviewed.
Ethics Statement
All participants gave written informed consent during the
ZAMSTAR 2010 Prevalence survey to be visited again for follow
up studies. All participants gave written informed consent for this
Access and Retention in Care Study. The study was approved by
the Stellenbosch University Committee for Human Research, the
Ethics Advisory Group of the International Union against TB and
Lung disease (The Union) and the Human Research Ethics
Committee at the Health Sciences Faculty of the University of
Cape Town.
Statistical analysis
Stata version 12 (Stata Corp.LP, College Station, TX, United
States of America) was used for all analyses. Standardisation was
used to account for the sex ratio of HIV prevalence in the Western
Cape according to the ASSA model [17]. Logistic regression with
robust standard errors to control parameter estimates for
clustering at a community level was used to explore factors
associated with retention in HIV care in the pre-ART group. The
impact of the following factors on the likelihood of retention in
pre-ART care was explored using a univariable regression: sex;
age; employment status; highest education level; years living in the
same area; history of previous TB treatment; mode of transport
and cost to reach the clinic at their last visit, overall waiting time at
the clinic; and knowing someone close to them who either had
HIV, was on ART or had died from HIV.
Results
872 randomly selected adults who reported that they were HIV
positive in the ZAMSTAR 2010 prevalence survey were included
and revisited (Figure 1). No statistical significant differences in age,
sex, employment or education were found between the group that
was randomly selected for this study and the group that was not
selected.
778 (89%) were willing to disclose their HIV status at the follow
up interview. 579 (66%) reconfirmed their positive status and were
included in this analysis. This group had significantly more females
than the 293 (34%) not included (87% vs 72%, p,0.001) and
significantly more unemployed (66% vs 42%, p,0.001).
Of the 579 participants included in this analysis 501 (87%) were
female (Table 1). The mean age of all participants was 36 years
with 445 (77%) between 25 and 44 years of age. 452 (78%) had
lived in the community for more than 5 years. 174 (30%) had only
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ever tested once for HIV, 237 (41%) had tested twice, and 162
(28%) had tested 3 or more times.
380 of the 579 participants (66%) were in the ART group of
whom 357 (94%) were retained in ART care (Table 2). Of the 357
retained in ART care 313 (88%) were female, the mean age was
36.2 years, 281 (79%) had secondary education, and 243 (68%)
were unemployed.
Due to the high retention in ART care, factors associated with
retention in ART care, were not analysed further
199 (34%) participants never initiated ART, of whom 186
(93%) accessed pre-ART care as evidenced by self reporting that
they had had at least one CD4 count in the past. 141 (76%) knew
the value of their last CD4 count, the mean was 548 cells/mm3
and the range from 101–2000 cells/mm3. 124 (67%) reported that
their first CD4 count had been taken on the same day that they
had tested positive for HIV. Two (1%) did not know if they had
ever had a CD4 count. Of those having had a CD4 count, 57
(31%) had only ever had one. Of the 186 people in the pre-ART
group who had accessed pre-ART care, 86 (43%) were retained in
pre-ART care (Table 2). Of the 86 retained in pre-ART care 80
(93%) were female, the mean age was 33.2 years, 75 (87%) had
secondary education, and 51 (59%) were unemployed.
Even though 113 in the pre-ART group were not retained in
pre-ART care 78 of these (69%) had accessed general health care
by attending a health care facility for any medical reason within
the last three months, but did not have a CD4 count done at that
attendance.
In the univariable analysis (Table 3) women were more likely to
be retained in pre-ART care (OR=3.0), but this association was
not statistically significant, possibly due to the small sample size of
the group under consideration. None of the other factors analysed
were significantly associated with retention in care in the pre-ART
group.
Discussion
This study described access to and retention in pre-ART and
retention in ART care in eight communities in the Western Cape.
This was a community-based rather than facility-based study and
Figure 1. Participant Flow Chart.
doi:10.1371/journal.pone.0096867.g001
Table 1. Demographic and HIV testing characteristics of study participants.
Study Participants (n =579) Subcategory N (%)
Sex Female 501 (87)
Male 78 (13)
Age categories in years
18–24 42 (7)
25–34 224 (39)
35–44 221 (38)
.45 92 (16)
Employment status
Unemployed 380 (66)
Employed either part time or full time 199 (34)
Years living in the community
,5 years 120 (21)
.5 years 452 (78)
Missing data 7 (1)
Number of times participants had tested for HIV
1 174 (30)
2 237 (41)
3 118 (20)
4 29 (5)
.4 15 (3)
Unknown or missing data 6 (1)
doi:10.1371/journal.pone.0096867.t001
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therefore included those who did not access care. The results
reflected that the majority of people on ART (94%) were retained
in ART care whilst less than half (43%) of those not on ART, were
retained in pre ART care, although no factors were significantly
associated with retention in care in the pre-ART group.
High levels of retention in ART care, as were found in this
study, have also been reported by studies in other settings [18–20].
The low levels of retention in pre-ART care needs to be
improved. In order for patients to be retained in care they need to
have access to primary health care facilities, with good quality
continuity of care from HIV diagnosis until ART eligibility and
initiation. In this study general access to primary health care
facilities was demonstrated to be good, with 78 (69%) of those who
did not have a CD4 count in the last 6 months having attended a
health care facility for any medical reason within the last three
months. However the quality of pre-ART care that they received
was poor – as they remained without a recent CD4 count. It is
essential that pre-ART patients have regular CD4 counts and that
ART is initiated as soon as indicated to decrease morbidity and
mortality associated with low CD4 counts [3,5,21]. Other studies
confirm poor retention in and quality of pre-ART care as patients
still initiate ART at low baseline CD4 counts (below 200 cells/
mm3) [5].
In South Africa there is a large gap between the resources that
have been expended on the ART programme, as opposed to a
pre-ART programme. A comprehensive pre-ART care package
that provides quality care to the patient from HCT through to
initiation on ART is lacking [9,22]. Patients are accessing health
care facilities, but need to be identified, retained and provided with
appropriate pre-ART care. In Cape Town, the policies for pre-
ART care are defined but have been incompletely translated into
practice [9]. In a 2010 audit on HCT and pre-ART care Scott et
al reported many missed opportunities for positive prevention
(Family planning, STI screening, PAP smears, and Tuberculosis
screening), as well as breaks in continuity of pre-ART care (clinical
staging, CD4 count measuring, referral for ART). They report
that in Cape Town pre-ART care, in contrast with ART care, has
not been allocated additional dedicated health care providers, but
has had to rely on existing staff who have been furnished with little
scale up support [9]. This is one reason for failure to transform a
pre-ART policy into pre-ART care practice.
It is important to determine factors associated with retention in
pre-ART care so that patient and provider related factors can be
strengthened. In this study, although no statistically significant
factors associated with retention in pre-ART care were found, the
odds ratios suggested that females and those knowing someone on
ART were more likely to be retained in pre-ART care. Likewise, a
range of factors associated with retention in or loss to pre-ART
care have been described in other studies [6,11,12,23,24]. In a
study in KwaZulu -Natal retention in pre-ART care was
associated with female sex as well as a lower initial CD4 count
and older age [12]. Factors influencing loss to pre-ART care
included distance from the health centre [6,11] male sex [6,11,23]
a low CD4 count [6,11] a history of being treated for TB, referral
for HIV testing by a health care provider as opposed to self-
referral, weight below 50 kg, unemployment [11] and younger age
[23]. A qualitative study, as part of the researching equity in access
to healthcare (REACH) project, found that continuing adherence
to ART was positively affected by social and economic support by
families, friends and the broader community, and negatively by
transport and food costs [25]. On-going targeting of vulnerable
groups such as men and the youth with initiatives like youth
clinics; non medical sites in the community offering HCT and
CD4 testing; HIV education and awareness campaigns, and
support groups may contribute to improved access and retention
in care.
There are several strengths to this study. This was a community-
based rather than health facility-based survey and thus participants
who had not attended health facilities were also included. To our
knowledge no other study determining retention in pre-ART and
ART care has sampled in this manner. The communities from
which we sampled had been exposed to the ZAMSTAR
interventions, and in general participants were knowledgeable
about their HIV testing history and were able to provide the
researchers with an accurate and comprehensive account of their
HIV testing pathway.
There are limitations to this study. The sample size for this study
was calculated to answer a different research question and
therefore the sample size of the subgroup reported in this analysis
might be too small to detect associations with sufficient precision.
Data such as CD4 results were self reported and not validated
against clinical records. As this was a self reported study factors
that may have been associated with retention in care such as initial
presenting CD4 count, weight at presentation, and the referral
method for HIV testing were unable to be determined from
clinical records. There may have been recall as well as reporting
bias. This study may not be generalizable to other areas in South
Africa as participants may have been more likely to be retained in
pre-ART and ART care due to their increased awareness of TB
and HIV as a result of their exposure to the ZAMSTAR study
interventions and we may have over-estimated retention in care. A
further limitation was the low response rate. 66% of the randomly
Table 2. Retention in ART and pre-ART care.
Study Participants (n =579) Subcategory N (%)
ART group 380 (66%)
Collected ART medication within the last three months of being interviewed 357 (94%)
Did not collect ART medication within the last three months of being interviewed 23 (6%)
pre-ART group 199 (34%)
Had a CD4 count within the last 6 months of being interviewed 86 (43%)
Did not have a CD4 count within the last 6 months of being interviewed 113 (57%)
Access to pre-ART care 199
Accessing pre-ART care (reported to have had at least one CD4 count) 186 (93%)
Did not access pre-ART care 13 (7%)
doi:10.1371/journal.pone.0096867.t002
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Table 3. Univariate analysis of factors that might be associated with retention in pre-ART care.
UNIVARIATE
pre-ART group Retention in pre-ART care
N (%) n (% of N) OR 95% CI p-value
Total 199 86 (43%)
Sex
Male 27 (14%) 6 (22%) 1.0
Female 172 (86%) 80 (47%) 3.0 0.8 12.0 0.112
Age category
15–24 21 (11%) 11 (52%) 1.0
25–34 91 (46%) 36 (40%) 0.5 0.2 1.1 0.067
35–44 70 (35%) 32 (46%) 0.4 0.1 1.6 0.217
45+ 17 (9%) 7 (41%) 0.6 0.1 3.3 0.578
Education level
Primary or none 28 (14%) 11 (39%) 1.0
Secondary or tertiary 171 (86%) 75 (44%) 1.1 0.3 3.7 0.862
Employment
Unemployed 119 (60%) 51 (43%) 1.0
Employed 80 (40%) 35 (44%) 1.2 0.6 2.8 0.613
Transport cost
No cost (walkers) 29 (15%) 13 (45%) 1.0
Some cost 163 (82%) 72 (44%) 0.7 0.4 1.5 0.392
missing 7 (4%) 1 (14%)
Travel time
0–29 mins 91 (46%) 41 (45%) 1.0
.=30 mins 101 (51%) 44 (44%) 1.0 0.5 2.0 0.946
missing 7 (4%) 1 (14%)
Waiting time
0–2 hr 66 (33%) 28 (42%) 1.0
2–4 hrs 88 (44%) 41 (47%) 1.3 0.7 2.6 0.429
.4 hrs 37 (19%) 16 (43%) 0.9 0.3 2.7 0.840
missing 8 (4%) 1 (13%)
Know HIV+ person
No one 44 (22%) 15 (34%) 1.0
Someone 152 (76%) 71 (47%) 0.8 0.2 2.6 0.655
missing 3 (2%) 0 (0%)
Know someone on ART
No one 72 (36%) 24 (33%) 1.0
Someone 126 (63%) 62 (49%) 1.6 0.6 4.0 0.369
missing 1 (1%) 0 (0%)
Knew someone who died of HIV
No one 96 (48%) 36 (38%) 1.0
Someone 102 (51%) 50 (49%) 1.4 0.5 4.2 0.507
missing 1 (1%) 0 (0%)
Previous TB treatment
No 137 (69%) 62 (45%) 1.0
Yes 62 (31%) 24 (39%) 0.7 0.3 1.5 0.326
Years in community
,5 years 43 (22%) 24 (56%) 1.0
.=5 years 154 (77%) 62 (40%) 0.9 0.3 2.5 0.847
missing 2 (1%) 0 (0%)
doi:10.1371/journal.pone.0096867.t003
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selected adults who were revisited reconfirmed their HIV status
and were enrolled. The adults who did not reconfirm their status
may have been reluctant to do so because they were not retained
in pre-ART or ART care, in which case our study may have over-
estimated retention in pre-ART and ART care.
Conclusion
With the introduction of guidelines enabling all PLWH to access
ART with a CD4 count ,350 cells/mm3 the South African ART
programme will continue to expand, and just as retention in ART
care is essential to achieve this goal, so too is retention in pre-ART
care. This study highlights the need for strengthening pre-ART
care. A systematic approach with attention to client and service
factors, such as clear pre-ART care policies, staff training and the
optimal provision and use of additional resources is needed to
increase retention in pre-ART care. This study, shows that missed
opportunities will be avoided and clients will be retained in pre-
ART care, if care is better integrated, and clinicians attend to the
comprehensive needs of clients in primary health care facilities.
Further studies, including those of a qualitative nature, that
explore reasons for default or non retention in pre-ART care will
also give valuable insight as to where to focus resources.
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